Javascript must be enabled to continue!
Abstract 13407: Trends in Discharge Prescription of Digoxin After Norwood Operation: An Analysis of Data From the Pediatric Health Information Systems Database (PHIS)
View through CrossRef
Background:
Quality improvement efforts have focused on reducing interstage mortality for infants with hypoplastic left heart syndrome (HLHS). In 2016 two publications reported that digoxin use was associated with reduced interstage mortality. The degree to which these findings have affected real world practice has not been evaluated.
Methods:
A multicenter retrospective cohort study of rates of digoxin prescription at discharge was performed of neonates with HLHS surviving to discharge without transplant from 1/2006-12/2018 at PHIS hospitals. A difference in difference analysis was performed using mixed effects models to adjust for measurable covariates (known arrhythmia, prematurity, renal insufficiency, etc.) with the hypothesis that the likelihood of digoxin prescription increased after 1/2016. Inter-hospital practice variation was measured, calculating the median odds ratio (MOR). Likelihood of furosemide and aspirin prescriptions were studied as falsification tests.
Results:
Over the study period 6091 subjects from 35 hospitals were included. Likelihood of receiving digoxin, furosemide, and aspirin are depicted (Figure). After adjusting for measurable covariates, discharge after 1/2016 was associated with increased odds of receiving digoxin (OR: 3.9, p<0.001). No association was seen between date of discharge and furosemide (p=0.26) or aspirin (p=0.12). Prior to 1/2016, the likelihood of receiving digoxin was decreasing (OR: 0.9 per year, p<0.001), while after 1/2016 the likelihood has increased (OR: 2.4 per year, p<0.001). Significant inter-hospital variation in the likelihood of receiving digoxin was seen (MOR=3.5, p<0.001 with no significant difference before and after 2016).
Conclusion:
The use of digoxin increased after publication of data about potential benefit in the interstage period. However, despite concerted quality improvement efforts, there is persistent large magnitude inter-hospital variation in practice.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract 13407: Trends in Discharge Prescription of Digoxin After Norwood Operation: An Analysis of Data From the Pediatric Health Information Systems Database (PHIS)
Description:
Background:
Quality improvement efforts have focused on reducing interstage mortality for infants with hypoplastic left heart syndrome (HLHS).
In 2016 two publications reported that digoxin use was associated with reduced interstage mortality.
The degree to which these findings have affected real world practice has not been evaluated.
Methods:
A multicenter retrospective cohort study of rates of digoxin prescription at discharge was performed of neonates with HLHS surviving to discharge without transplant from 1/2006-12/2018 at PHIS hospitals.
A difference in difference analysis was performed using mixed effects models to adjust for measurable covariates (known arrhythmia, prematurity, renal insufficiency, etc.
) with the hypothesis that the likelihood of digoxin prescription increased after 1/2016.
Inter-hospital practice variation was measured, calculating the median odds ratio (MOR).
Likelihood of furosemide and aspirin prescriptions were studied as falsification tests.
Results:
Over the study period 6091 subjects from 35 hospitals were included.
Likelihood of receiving digoxin, furosemide, and aspirin are depicted (Figure).
After adjusting for measurable covariates, discharge after 1/2016 was associated with increased odds of receiving digoxin (OR: 3.
9, p<0.
001).
No association was seen between date of discharge and furosemide (p=0.
26) or aspirin (p=0.
12).
Prior to 1/2016, the likelihood of receiving digoxin was decreasing (OR: 0.
9 per year, p<0.
001), while after 1/2016 the likelihood has increased (OR: 2.
4 per year, p<0.
001).
Significant inter-hospital variation in the likelihood of receiving digoxin was seen (MOR=3.
5, p<0.
001 with no significant difference before and after 2016).
Conclusion:
The use of digoxin increased after publication of data about potential benefit in the interstage period.
However, despite concerted quality improvement efforts, there is persistent large magnitude inter-hospital variation in practice.
Related Results
Association of Digoxin Use at Norwood Discharge with Fontan Completion: A Study from the Pediatric Heart Network Public Dataset
Association of Digoxin Use at Norwood Discharge with Fontan Completion: A Study from the Pediatric Heart Network Public Dataset
Abstract
Background
Digoxin use after the Norwood procedure has been associated with improved interstage survival in hypoplasti...
Clinical signs and symptoms of toxic serum digoxin levels in neonates
Clinical signs and symptoms of toxic serum digoxin levels in neonates
Digoxin is widely used in the treatment of congestive heart failure and some arrhythmias. Digoxin toxicity may occur easily because digoxin has a narrow therapeutic index. This ret...
Radioimmunoassay of Digoxin—Interference by Digitoxin
Radioimmunoassay of Digoxin—Interference by Digitoxin
Abstract
Digitoxin interference with radioimmunoassay of digoxin may present a problem in determining digoxin concentrations in the serum of patients treated with di...
Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
Background: Digoxin is extensively prescribed for cardiac diseases, so its chronic or acute toxicity commonly occur. Although digoxin specific antibodies (anti-digoxin Fab) are rec...
Abstract 12806: Attributable Mortality Benefit of Digoxin Treatment in Hypoplastic Left Heart Syndrome After the Norwood Operation
Abstract 12806: Attributable Mortality Benefit of Digoxin Treatment in Hypoplastic Left Heart Syndrome After the Norwood Operation
Introduction:
Observational studies have demonstrated an association between digoxin treatment and lower interstage mortality after Norwood operation for hypoplastic le...
The Pediatric Anesthesiology Workforce: Projecting Supply and Trends 2015–2035
The Pediatric Anesthesiology Workforce: Projecting Supply and Trends 2015–2035
BACKGROUND:
A workforce analysis was conducted to predict whether the projected future supply of pediatric anesthesiologists is balanced with the requirements o...
Surveillance of Digoxin Concentrations in Critically Ill Individuals with Heart Failure
Surveillance of Digoxin Concentrations in Critically Ill Individuals with Heart Failure
Background and Objectives: Digoxin is a pharmacological agent of natural origin that is still occasionally administered in the intensive care unit (ICU). The objective of this stud...
Pediatric Pilonidal Sinus Disease: A Single-Center Cohort Study of Clinical and Surgical Outcomes
Pediatric Pilonidal Sinus Disease: A Single-Center Cohort Study of Clinical and Surgical Outcomes
Abstract
Introduction: Pilonidal sinus disease is increasingly recognized in the pediatric population, yet evidence on its clinical characteristics and surgical outcomes in childre...

